Hedge Fund - Cryder Capital
Thermo Fisher Scientific Inc. (TMO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $214,637,145 | 10.62% | 404,373 | $484.03 |
| 2 | 2023 - Q3 (2023-09-30) | $198,464,195 | 9.58% | 392,090 | $532.87 |
| 3 | 2023 - Q2 (2023-06-30) | $205,255,407 | 10% | 393,398 | $539.63 |
| 4 | 2023 - Q1 (2023-03-31) | $227,482,288 | 12.09% | 394,681 | $563.62 |
| 5 | 2022 - Q4 (2022-12-31) | $217,346,880 | 13.44% | 394,681 | $529.89 |
| 6 | 2022 - Q3 (2022-09-30) | $219,374,000 | 13.6% | 432,528 | $559.63 |
| 7 | 2022 - Q2 (2022-06-30) | $235,199,000 | 12.83% | 432,925 | $550.42 |
| 8 | 2022 - Q1 (2022-03-31) | $237,629,000 | 11.67% | 402,317 | $574.45 |
| 9 | 2021 - Q4 (2021-12-31) | $258,112,000 | 11.68% | 386,836 | $624.35 |
| 10 | 2021 - Q3 (2021-09-30) | $221,011,000 | 11.03% | 386,836 | $548.85 |
| 11 | 2021 - Q2 (2021-06-30) | $193,354,000 | 10.04% | 383,281 | $471.83 |
| 12 | 2021 - Q1 (2021-03-31) | $136,269,000 | 9.73% | 298,587 | $477.30 |
| 13 | 2020 - Q4 (2020-12-31) | $136,096,000 | 10.86% | 292,189 | $468.87 |
| 14 | 2020 - Q3 (2020-09-30) | $156,439,000 | 14.54% | 354,319 | $413.14 |
| 15 | 2020 - Q2 (2020-06-30) | $128,384,000 | 13.9% | 354,319 | $335.19 |
| 16 | 2020 - Q1 (2020-03-31) | $100,485,000 | 14.64% | 354,319 | $315.33 |
| 17 | 2019 - Q4 (2019-12-31) | $129,357,000 | 14.66% | 398,180 | $303.22 |
| 18 | 2019 - Q3 (2019-09-30) | $120,611,000 | 15.48% | 414,088 | $286.35 |
| 19 | 2019 - Q2 (2019-06-30) | $117,663,000 | 17.4% | 400,650 | $275.43 |
| 20 | 2019 - Q1 (2019-03-31) | $109,666,000 | 16.86% | 400,650 | $248.87 |
| 21 | 2018 - Q4 (2018-12-31) | $88,969,000 | 16.19% | 397,554 | $234.62 |
| 22 | 2018 - Q3 (2018-09-30) | $99,886,000 | 15.36% | 409,235 | $230.05 |
| 23 | 2018 - Q2 (2018-06-30) | $84,646,000 | 13.82% | 408,643 | $212.27 |
| 24 | 2018 - Q1 (2018-03-31) | $51,102,000 | 14.68% | 247,513 | $209.90 |
| 25 | 2017 - Q4 (2017-12-31) | $44,719,000 | 14.41% | 235,513 | $191.57 |
| 26 | 2017 - Q3 (2017-09-30) | $36,584,000 | 14.93% | 193,360 | $181.11 |
| 27 | 2017 - Q2 (2017-06-30) | $33,736,000 | 12.36% | 193,360 | $167.97 |
| 28 | 2017 - Q1 (2017-03-31) | $29,700,000 | 12.04% | 193,360 | $152.84 |
| 29 | 2016 - Q4 (2016-12-31) | $27,132,000 | 12.11% | 192,286 | $147.43 |
| 30 | 2016 - Q3 (2016-09-30) | $26,198,000 | 15.35% | 164,704 | $154.10 |
| 31 | 2016 - Q2 (2016-06-30) | $18,459,000 | 14.8% | 124,924 | $147.59 |
| 32 | 2016 - Q1 (2016-03-31) | $15,987,000 | 12.23% | 112,911 | $134.01 |
| 33 | 2015 - Q4 (2015-12-31) | $15,827,000 | 13.29% | 111,575 | $133.38 |
| 34 | 2015 - Q3 (2015-09-30) | $16,686,000 | 10.78% | 136,458 | $130.28 |
| 35 | 2015 - Q2 (2015-06-30) | $12,465,000 | 9.03% | 96,063 | $130.37 |
| 36 | 2015 - Q1 (2015-03-31) | $12,556,000 | 8.84% | 93,468 | $128.92 |
The displayed share prices are average quarterly stock market prices.